Press releases

Month Year

Email alerts

Sep 11, 2014

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

Superior Deliverabilityi and Uncompromising Performance Distinguishes New Angioplasty Balloon

MINNEAPOLIS -- Sept. 11, 2014 -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora(TM) Noncompliant Balloon...
Sep 11, 2014

Medtronic Named One of the World's Leading Companies for Sustainability

MINNEAPOLIS - Sept. 11, 2014 - Medtronic, Inc. (NYSE: MDT) was recognized as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability World Index...
Sep 10, 2014

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

First Patients Successfully Treated in Study to Evaluate Next Generation Transcatheter Valve

MINNEAPOLIS - Sept. 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the...
Sep 3, 2014

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

Next-Generation TAVI System Offers Ability to Recapture and Reposition During Deployment

MINNEAPOLIS - Sept. 3, 2014 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM) R System for transcatheter aortic valve implantation...
Sep 2, 2014

Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference

MINNEAPOLIS - Sept 2, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global Healthcare Conference,...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa